Page 727 - Cardiac Nursing

49
tar
p65
/1/
09
703
g
P
Ap
AM
7
0-c
28_
5-7
K34
LWB K34 0-c 28_ p65 5-7 04. qxd 7 /1/ 09 9: 49 AM P a a g e e 703 Ap tar a a
LWBK340-c28_p655-704.qxd 7/1/09 9:9:49 AM Page 703 Aptara
LWB
04.
qxd
C HAPTER 2 8 / Pacemakers and Implantable Defibrillators 703
41. Lamas, G. A., Lee, K. L., Sweeney, M. O., et al. (2002). Ventricular pac- 64. Connolly, S. J., Gent, M., Roberts, R. S., et al. (2000). Canadian Im-
ing or dual-chamber pacing for sinus-node dysfunction. New England plantable Defibrillator Study (CIDS): A randomized trial of the implantable
6
Journal of Medicine, 346(24), 1854–1862. cardioverter defibrillator against amiodarone. Circulation, 101, 1297–1302.
6
42. Ritter, O., Koller, M. L., Fey, B., et al. (2006). Progression of heart fail- 65. Engelstein, E. D. (2003). Prevention and management of chronic heart fail-
ure in right univentricular pacing compared to biventricular pacing. In- ure with electrical therapy. American Journal of Cardiology, 91(9A), 62–73.
ternational Journal of Cardiology, 110, 359–365. 66. Wathen, M. (2007). Implantable cardioverter defibrillator shock reduc-
43. Manolis, A. S. (2006). The deleterious consequences of right ventricular tion using new antitachycardia pacing therapies. American Heart Journal,
apical pacing: Time to seek alternate site pacing. Pacing and Clinical Elec- 153(4, Suppl. 1), 44–52.
trophysiology, 29(3), 298–315. 67. Schoels, W., Steinhaus, D., Johnson, W. B., et al. (2007). Optimizing im-
44. Healey, J. S., Morillo, C. A., & Connolly, S. J. (2007). Clinical trials of plantable cardioverter-defibrillator treatment of rapid ventricular tachy-
pacing modes. In K. A. Ellenbogen, G. N. Kay, C.-P. Lau, et al. (Eds.), cardia: Antitachycardia pacing therapy during charging. Heart Rhythm,
Clinical cardiac pacing, defibrillation, and resynchronization therapy (3rd 4(7), 879–885.
ed., pp. 337–356). Philadelphia: Saunders Elsevier. 68. Bass, E. B., Elson, J. J., Fogoros, R. N., et al. (1988). Long-term prog-
45. Olshansky, B., Day, J., McGuire, M., et al. (2005). Inhibition of unneces- nosis of patients undergoing electrophysiologic studies for syncope of un-
sary RV pacing with AV search hysteresis in ICDs (INTRINSIC RV): De- known origin. American Journal of Cardiology, 62, 1186–1191.
sign and clinical protocol. Pacing and Clinical Electrophysiology, 28, 62–66. 69. Moss, A., Hall, J., Cannom, D. et al., for the Multicenter Automatic
46. Olshansky, B., Day, J. D., Moore, S., et al. (2007). Is dual-chamber pro- Defibrillator Implantation Trial. (1996). Improved survival with an im-
gramming inferior to single-chamber programming in an implantable car- planted defibrillator in patients with coronary disease at high risk for
dioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Un- ventricular arrhythmia. New England Journal of Medicine, 335,
necessary RV Pacing With AVSH in ICDs) Study. Circulation, 115, 9–16. 1933–1940.
47. Sweeney, M. O., Ellenbogen, K. A., Casavant, D., et al. (2005). Multi- 70. Kadish, A., Dyer, A., Daubert, J. P., et al. (2004). Prophylactic defibril-
center, prospective, randomized safety and efficacy study of a new atrial- lator implantation in patients with non-ischemic dilated cardiomyopa-
based managed ventricular pacing mode (MVP) in dual chamber ICDs. thy. New England Journal of Medicine, 350, 2151–2158.
6
6
Journal of Cardiovascular Electrophysiology, 16, 811–817. 71. Hohnloser, S. H., Kuck, K. H., Dorian, P., et al. (2004). Prophylactic use
48. Byrd, C. L. (2007). Managing device-related complications and transve- of an implantable cardioverter-defibrillator after acute myocardial infarc-
nous lead extraction. In K. A. Ellenbogen, G. N. Kay, C.-P. Lau, et al. tion. New England Journal of Medicine, 351(24), 2481–2488.
(Eds.), Clinical cardiac pacing, defibrillation, and resynchronization ther- 72. Dimarco, J. P. (2003). Implantable cardioverter-defibrillators. New
apy (3rd ed., pp. 855–930). Philadelphia: Saunders Elsevier. England Journal of Medicine, 349, 1836–1847.
49. Bailey, S. M., & Wilkoff, B. L. (2006). Complications of pacemakers and 73. Kroll, M.W., & Levine P.A. (2007). Pacemaker and implantable car-
defibrillators in the elderly. American Journal of Geriatric Cardiology, 15(2), dioverter-defibrillator circuitry. In K. Ellenbogen, G. N. Kay, C. P. Lau,
102–107. et al. (Eds.), Clinical cardiac pacing, defibrillation; and resynchronization
50. Moss, A. J., Zareba, W., Hall, W. J., et al. (2002) for the Multicenter Auto- therapy (pp. 261–278). Philadelphia: Saunders Elsevier.
matic Defibrillator Implantation Trial II Investigators. Prophylactic implan- 74. St. Jude Medical. (2005). What’s Inside and ICD (Brochure). Sylmar, CA.
tation of a defibrillator in patients with myocardial infarction and reduced 75. Kleemann, T., Becker, T., Doenges, S., et al. (2007). Annual rate of trans-
ejection fraction. New England Journal of Medicine, 346(12), 877–883. venous defibrillation lead defects in implantable cardioverter-defibrillators
6
6
51. Bardy, G. H., Lee K. L, Mark D. B., et al. (2005). Amiodarone or an im- over a period of 10 years. Circulation, 115, 2474–2480.
plantable cardioverter defibrillator for congestive heart failure. New 76. Henry, P. D., & Pacifico, A. (2002). Defibrillator leads. In A. Pacifico
England Journal of Medicine, 352, 225–237. (Ed.), Implantable defibrillator therapy: A clinical guide (pp. 43–62).
52. Mirowski, M. (1985). The automatic implantable cardioverter-defibrilla- Boston: Kluwer Academic Publishers.
tor: An overview. American Journal of Cardiology, 6, 461–466. 77. Russo, A. M., & Marchlinski, F. E. (2007). Engineering and construction
6
6
53. Gold, M. R. (2000). ICD therapy in the new millennium. Cardiology of pacemaker and implantable cardioverter-defibrillator leads. In K. El-
Clinics, 18(2), 375–389. lenbogen, G. N. Kay, C. P. Lau, et al. (Eds.), Clinical cardiac pacing, de-
54. Swerdlow, C. D., Gillberg, J. M., & Olson, W. H. (2007). Sensing and de- fibrillation, and resynchronization therapy (pp. 161–200). Philadelphia:
tection. In K. A. Ellenbogen, G. N. Kay, C. P. Lau, et al. (Eds.), Clinical Saunders Elsevier.
cardiac pacing, defibrillation, and resynchronization therapy (pp. 75–160). 78. Bardy, G. H., Johnson, G., Poole, J. E., et al. (1993). A simplified, single-lead
Philadelphia: Saunders Elsevier. unipolar transvenous cardioversion-defibrillation system. Circulation, 88,
55. Goldberger, Z., & Lampert, R. (2006). Implantable cardioverter-defib- 543–547.
rillators–expanding indications and technologies. JAMA, 295(7), 79. Glikson, M., Swerdlow, C. D., Gurevitz, O. T., et al. (2005). Optimal
809–818. combination of discriminators for differentiating ventricular from
56. Zipes, D. P., Camm, A. J., et al. (2006). ACC/AHA/ESC 2006 guide- supraventricular tachycardia by dual chamber defibrillators. Journal of
6
lines for management of patients with ventricular arrhythmias and the Cardiovascular Electrophysiology, 16, 732–739.
6
prevention of sudden cardiac death—executive summary. Journal of the 80. Zivin, A. Z., & Bardy, G. H. (2002). Device testing and programming
American College of Cardiology, 48(5), 1064–1108. at implant. In A. Pacifico (Ed.), Implantable defibrillator therapy: A clini-
57. Gehi, A. K., Mehta, D., & Gomes, J. A. (2006). Evaluation and man- cal guide. (pp. 113–137). Boston: Kluwer Academic Publishers.
agement of patients after implantable cardioverter–defibrillator shock. 81. Klein, G. J., Gillberg, J. M., Tang, A., et al. (2006). Improving SVT dis-
JAMA, 296(23), 2839–2847. crimination in single-chamber ICDs: A new electrogram morphology based
6
6
7
7
58. Podrid, P. J., & Myerburg, R. J. (2005). Epidemiology and stratification algorithm. Journal of Cardiovascular Electrophysiology, 17(12), 1310–1319.
of risk for sudden cardiac death. Clinical Cardiology, 28, 3–11. 82. Theuns, D. A., Rivero-Ayerza, M., Goedhart, D. M., et al. (2006). Evalu-
59. Siddiqui, A., & Kowey, P. R. (2006). Sudden death secondary to cardiac ation of morphology discrimination for ventricular tachycardia diagnosis in
arrhythmias: Mechanisms and treatment strategies. Current Opinion in implantable cardioverter-defibrillators. Heart Rhythm Society, 3(11),
Cardiology, 21, 517–525. 1332–1338.
60. Cobb, L. A., Baum, R. S., Alvarez, H., et al. (1975). Resuscitation from 83. Russo, A. M., & Marchlinski, F. E. (2002). Long-term follow-up. In A.
out-of-hospital ventricular fibrillation: 4-year follow-up. Circulation, Pacifico (Ed.), Implantable defibrillator therapy: A clinical guide
52(Suppl. III), 23. (pp. 161–243). Boston: Kluwer Academic Publishers.
61. Cappato, R. (1999). Secondary prevention of sudden death: The Dutch 84. Sweeney, M. O., Wathen, M. S., & Volosin, K. (2005). Appropriate and
Study, the Antiarrhythmic Versus Implantable Defibrillator Study. Amer- inappropriate ventricular therapies, quality of life, and mortality among
ican Journal of Cardiology,83(Suppl.), 68D–73D. primary and secondary prevention implantable cardioverter defibrillator
62. The Antiarrhythmics vs. Implantable Defibrillators (AVID) Investiga- patients: Results from the pacing fast VT Reduces Shock ThErapies
tors. (1997). A comparison of antiarrhythmic drug therapy with im- (PainFREE Rx II) trial. Circulation, 111, 2898–2905.
plantable defibrillators in patients resuscitated from near fatal ventricular 85. Wathen, M. S., DeGroot, M. S., Sweeney, M. O., et al. (2004). Prospec-
arrhythmias. New England Journal of Medicine, 337, 1576–1583. tive randomized multicenter trial of empirical antitachycardia pacing ver-
7
7
63. Kuck, K. H., Cappato, R., Siebels, J., et al. (2000). Randomized com- sus shocks for spontaneous rapid ventricular tachycardia in patients with
parison of antiarrhythmic drug therapy with implantable defibrillators in implantable cardioverter-defibrillators: Pacing fast ventricular tachycardia
patients resuscitated from cardiac arrest: The Cardiac Arrest Study Ham- reduces shock therapies (PainFREE Rx II) trial results. Circulation, 110,
burg (CASH). Circulation, 102, 748–754. 2591–2596.